
On November 21, 2025, the results of the 2025 elections for the Chinese Academy of Sciences (CAS) and the Chinese Academy of Engineering (CAE) were officially announced, with a total of 144 individuals elected. Zhu Lan, Director of the Department of Obstetrics and Gynecology at Peking Union Medical College Hospital (PUMCH), was elected as an Academician of the Chinese Academy of Sciences. This brings the total number of academicians at PUMCH to 4, with 2 being CAS academicians and 2 being CAE academicians.
Personal Profile
Zhu Lan, born in March 1964, is a member of the Communist Party of China. She serves as Chief Physician and Director of the Department of Obstetrics and Gynecology at PUMCH; tenured Professor at Peking Union Medical College; Academic Advisory Committee member of the Chinese Academy of Medical Sciences; incoming Chair of the Chinese Society of Obstetrics and Gynecology under the Chinese Medical Association; incoming Chair of the Chinese Obstetricians and Gynecologists Association under the Chinese Medical Doctor Association; member of the Central Healthcare Expert Group, and Foreign Member of the French College of Gynecologists and Obstetricians (CNGOF).
She received her bachelor's degree from Suzhou Medical College in 1986; in 1989, she was admitted to Peking Union Medical College, where she subsequently obtained her master's and doctoral degrees. From 1993 to present, she has been working in the Department of Obstetrics and Gynecology at PUMCH & Chinese Academy of Medical Sciences. During this period, she served as a visiting scholar at Prince of Wales Hospital, Chinese University of Hong Kong from November 1997 to April 1998, and at Liverpool Hospital, University of New South Wales, Australia from August 1998 to February 1999. She earned a fast-tracked promotion to Associate Chief Physician in 1999 and then to Chief Physician in 2005. From November 2010 to June 2020, she served as Deputy Director of the Department of Obstetrics and Gynecology and then Director of the General Gynecology Center at PUMCH. Since June 2020, she has served as Director of the Department of Obstetrics and Gynecology at PUMCH.
Research Directions and Academic Contributions
Professor Zhu Lan initiated and established China's specialty in gynecological pelvic floor disorders, refined theories on pelvic floor anatomical reconstruction and functional restoration, and pioneered original surgical techniques such as the "Xiehe (PUMCH) method" for pelvic floor reconstruction, increasing the success rate of pelvic organ prolapse surgery from 54% to over 95%, while reducing complication rates from 11.4% to 2.4%. She pioneered China's prevention and treatment model for pelvic floor diseases; the widespread adoption of postpartum pelvic floor rehabilitation in China has reduced the prevalence of urinary incontinence among Chinese adult women from 31% to 16%.
She led a collaboration among 22 renowned hospitals from China and seven developed countries including the United States and some European countries to establish the world's largest cohort with the most widespread patient distribution for congenital reproductive tract malformations—a rare pelvic floor disease—conducting joint research on pathogenic genes and molecular mechanisms, proposing clinical classification and fertility preservation strategies, and leading the Chinese-European expert consensus, etc., establishing China as a world leader in clinical care for reproductive malformations. She conducted research on cervical cancer prevention and control in underserved areas of China and was invited to present China's approach as an exemplary model at the United Nations headquarters, providing critical insights to support China's cervical cancer elimination targets.
As corresponding author, she has published 2 SCI papers in BMJ and 200 SCI papers in journals such as JAMA, Lancet, Cell, and Nature Medicine. Her clinical research findings have been incorporated into 7 international guidelines, and she has led the development of 3 Chinese group standards and 18 guidelines and consensus documents. She twice won the Second Prize of the State Scientific and Technological Progress Award (as the first and ninth contributor respectively), and also received a prize from the Ho Leung Ho Lee Foundation and the Tan Jiazhen Life Science Award. She was selected as one of the World's Top 2% Scientists in 2024. Through her pioneering research and theoretical advances in gynecological diseases, combined with robust clinical translation, she has made exceptional contributions to women's health in China.
Compiled by Chen Xiao
Photographed by Sun Liang
Edited by Xiao Xiong
Chief Editor Duan Wenli
Supervised by Wu Peixin